Two Onc Docs cover image

Bone Modifying Agents

Two Onc Docs

00:00

Introduction

Exploring the role of Bisphosphonates and Denosumab in reducing skeletal related events in cancer patients with bone metastases, emphasizing their importance for healthcare professionals in oncology and internal medicine.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app